Enhanced ex vivo intestinal absorption of olmesartan medoxomil nanosuspension: Preparation by combinative technology

The purpose of this study was to develop nanosuspension based on combinative technology to enhance the intestinal absorption of Olmesartan medoxomil (OLM), a potent antihypertensive agent with limited oral bioavailability. Two combinative approaches were employed and then characterized. In vitro int...

Descripción completa

Detalles Bibliográficos
Autores principales: Attari, Zenab, Bhandari, Amita, Jagadish, P.C., Lewis, Shaila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720021/
https://www.ncbi.nlm.nih.gov/pubmed/26903769
http://dx.doi.org/10.1016/j.jsps.2015.03.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720021/
https://www.ncbi.nlm.nih.gov/pubmed/26903769
http://dx.doi.org/10.1016/j.jsps.2015.03.008

Ejemplares similares